A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion

被引:0
作者
Gu, Rumeng [1 ,2 ]
Jiang, Luxi [1 ]
Duan, Ting [1 ]
Chen, Chun [1 ]
Wu, Shengchang [1 ]
Mu, Deguang [1 ]
机构
[1] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Resp Med, Hangzhou, Zhejiang, Peoples R China
[2] Bengbu Med Coll, Grad Sch Clin Med, Bengbu, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2021年 / 14卷
关键词
malignant pleural mesothelioma; pleural effusion; asbestos; PHASE-II TRIAL; TRIMODALITY THERAPY; ASBESTOS EXPOSURE; MANAGEMENT; DIAGNOSIS; SURGERY; PNEUMONECTOMY; GUIDELINES; CISPLATIN;
D O I
10.2147/OTT.S315869
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that originates from pleural mesothelial cells. In recent years, with the development of asbestos related industries and the increase in air pollution, its incidence has been increased. The incidence of pulmonary embolism combined with sarcomatoid MPM is very low and the prognosis is extremely poor. We here report a case of a patient with long term of pleural effusion and finally diagnosed as pulmonary embolism with sarcomatoid MPM. Case: A 75-year-old male with a 30-year history of asbestos exposure was admitted to our hospital due to chest pain and difficulty in breathing after exercise. Radiologic examination revealed pleural effusion, computed tomography pulmonary angiography (CTPA) suggests pulmonary embolism, and we consider pleural effusion caused by pulmonary embolism. After anticoagulant therapy for pulmonary embolism and pleural puncture to reduce pleural effusion, the patient's symptoms improved. However, after that, the patient was still admitted to the hospital several times because of recurrent chest pain and dyspnea symptoms, and radiologic examination always showed unexplained pleural effusion. Finally, pathological and immunohistochemical examinations of the pleural biopsy specimens were performed, and the diagnosis was confirmed as sarcomatoid MPM. Conclusion: In summary, sarcomatoid MPM with pulmonary embolism is relatively rare, and the prognosis is poor. Clinicians need to be alert to its occurrence. When the first diagnosis is confirmed and the effect of targeted treatment is still not good, the possibility of other diseases should be considered. In clinical practice, pleural biopsy guided by PET-CT is a good choice for patients with sarcomatoid MPM who cannot tolerate open pleural biopsies or thoracoscopy. And patients should undergo pleural morphology and immunohistochemistry as soon as possible, which are helpful for timely diagnosis.
引用
收藏
页码:4231 / 4237
页数:7
相关论文
共 34 条
  • [1] Malignant Pleural Mesothelioma: From the Bench to the Bedside
    Astoul, P.
    Roca, E.
    Galateau-Salle, F.
    Scherpereel, A.
    [J]. RESPIRATION, 2012, 83 (06) : 481 - 493
  • [2] Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales
    Beckett, P.
    Edwards, J.
    Fennell, D.
    Hubbard, R.
    Woolhouse, I.
    Peake, M. D.
    [J]. LUNG CANCER, 2015, 88 (03) : 344 - 348
  • [3] GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung
    Berg, Kyra B.
    Churg, Andrew
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (09) : 1221 - 1225
  • [4] The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence
    Bertoglio, Pietro
    Waller, David A.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 663 - 672
  • [5] Systematic review of trimodality therapy for patients with malignant pleural mesothelioma
    Cao, Christopher
    Tian, David
    Manganas, Con
    Matthews, Phoebe
    Yan, Tristan D.
    [J]. ANNALS OF CARDIOTHORACIC SURGERY, 2012, 1 (04) : 428 - 437
  • [6] Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
    Eguchi, Takashi
    Kadota, Kyuichi
    Mayor, Marissa
    Zauderer, Marjorie G.
    Rimner, Andreas
    Rusch, Valerie W.
    Travis, William D.
    Sadelain, Michel
    Adusumilli, Prasad S.
    [J]. ONCOTARGET, 2017, 8 (44) : 77872 - 77882
  • [7] Diagnostic work-up of pleural effusions
    Froudarakis, Marios E.
    [J]. RESPIRATION, 2008, 75 (01) : 4 - 13
  • [8] Improving the Accuracy of Mesothelioma Diagnosis in China
    Guo, Zhenying
    Carbone, Michele
    Zhang, Xing
    Su, Dan
    Sun, Wenyong
    Lou, Jianlin
    Gao, Zhibin
    Shao, Dichu
    Chen, Junqiang
    Zhang, Gu
    Hu, Jinlin
    Chen, Kaiyan
    Wang, Fang
    Pass, Harvey I.
    Yu, Herbert
    Napolitano, Andrea
    Yang, Haining
    Mao, Weimin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (04) : 714 - 723
  • [9] IDELL S, 1995, AM J PATHOL, V147, P1318
  • [10] Venous thrombosis in cancer patients: Insights from the FRONTLINE survey
    Kakkar, AK
    Levine, M
    Pinedo, HM
    Wolff, R
    Wong, J
    [J]. ONCOLOGIST, 2003, 8 (04) : 381 - 388